These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 26919664)

  • 1. Neuro-QoL health-related quality of life measurement system: Validation in Parkinson's disease.
    Nowinski CJ; Siderowf A; Simuni T; Wortman C; Moy C; Cella D
    Mov Disord; 2016 May; 31(5):725-33. PubMed ID: 26919664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validity of the Neurology Quality-of-Life (Neuro-QoL) measurement system in adult epilepsy.
    Victorson D; Cavazos JE; Holmes GL; Reder AT; Wojna V; Nowinski C; Miller D; Buono S; Mueller A; Moy C; Cella D
    Epilepsy Behav; 2014 Feb; 31():77-84. PubMed ID: 24361767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of the Neuro-QoL measurement system in children with epilepsy.
    Lai JS; Nowinski CJ; Zelko F; Wortman K; Burns J; Nordli DR; Cella D
    Epilepsy Behav; 2015 May; 46():209-14. PubMed ID: 25862469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric evaluation of the pediatric and parent-proxy Patient-Reported Outcomes Measurement Information System and the Neurology and Traumatic Brain Injury Quality of Life measurement item banks in pediatric traumatic brain injury.
    Bertisch H; Rivara FP; Kisala PA; Wang J; Yeates KO; Durbin D; Zonfrillo MR; Bell MJ; Temkin N; Tulsky DS
    Qual Life Res; 2017 Jul; 26(7):1887-1899. PubMed ID: 28271316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation of Neuro-QoL and PROMIS Mental Health Patient Reported Outcome Measures in Persons with Huntington Disease.
    Carlozzi NE; Goodnight S; Kratz AL; Stout JC; McCormack MK; Paulsen JS; Boileau NR; Cella D; Ready RE
    J Huntingtons Dis; 2019; 8(4):467-482. PubMed ID: 31424415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Responsiveness to change over time and test-retest reliability of the PROMIS and Neuro-QoL mental health measures in persons with Huntington disease (HD).
    Carlozzi NE; Boileau NR; Roché MW; Ready RE; Perlmutter JS; Chou KL; Barton SK; McCormack MK; Stout JC; Cella D; Miner JA; Paulsen JS
    Qual Life Res; 2020 Dec; 29(12):3419-3439. PubMed ID: 32813263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HDQLIFE and neuro-QoL physical function measures: Responsiveness in persons with huntington's disease.
    Carlozzi NE; Boileau NR; Chou KL; Ready RE; Cella D; McCormack MK; Miner JA; Dayalu P
    Mov Disord; 2020 Feb; 35(2):326-336. PubMed ID: 31724237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validating Neuro-QoL short forms and targeted scales with people who have multiple sclerosis.
    Miller DM; Bethoux F; Victorson D; Nowinski CJ; Buono S; Lai JS; Wortman K; Burns JL; Moy C; Cella D
    Mult Scler; 2016 May; 22(6):830-41. PubMed ID: 26238464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability and Validity of 39-Item Parkinson's Disease Questionnaire and Parkinson's Disease Quality of Life Questionnaire.
    Jesus-Ribeiro J; Vieira E; Ferreira P; Januário C; Freire A
    Acta Med Port; 2017 May; 30(5):395-401. PubMed ID: 28865504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the World Health Organization Quality of Life Assessment Short Version in Mild to Moderate Parkinson Disease.
    Hendred SK; Foster ER
    Arch Phys Med Rehabil; 2016 Dec; 97(12):2123-2129.e1. PubMed ID: 27343346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating cognition in individuals with Huntington disease: Neuro-QoL cognitive functioning measures.
    Lai JS; Goodnight S; Downing NR; Ready RE; Paulsen JS; Kratz AL; Stout JC; McCormack MK; Cella D; Ross C; Russell J; Carlozzi NE
    Qual Life Res; 2018 Mar; 27(3):811-822. PubMed ID: 29222609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Longitudinal Change in Quality of Life in Neurological Disorders Measures Over 3 Years in Patients with Early Parkinson's Disease.
    Marras C; Mills KA; Eberly S; Oakes D; Chou KL; Halverson M; Parashos SA; Tarolli CG; Lai JS; Nowinsky CJ; Suchowersky O; Farbman ES; Shulman LM; Simuni T
    Mov Disord; 2021 Aug; 36(8):1979-1983. PubMed ID: 33983638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing health-related quality of life with the SCOPA-PS in French individuals with Parkinson's disease having undergone DBS-STN: A validation study.
    Soulas T; Storme M; Martínez-Martín P; Pichlak M; Gurruchaga JM; Palfi S; Fénelon G
    Rev Neurol (Paris); 2016; 172(4-5):281-8. PubMed ID: 27158039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity, Reliability, and Insights from Applying the McGill Quality of Life Questionnaire to People Living with Parkinson's Disease (MQoL-PD).
    Gofton TE; Kumar H; Roberts-South A; Speechley M; Jog MS
    J Palliat Care; 2015; 31(4):213-20. PubMed ID: 26856121
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Satisfaction with Life Scale (SLS-6): First validation study in Parkinson's disease population.
    Ambrosio L; Portillo MC; Rodriguez-Blazquez C; Martínez-Castrillo JC; Rodriguez-Violante M; Serrano-Dueñas M; Campos-Arillo V; Garretto NS; Arakaki T; Álvarez M; Pedroso-Ibáñez I; Carvajal A; Martinez-Martin P
    Parkinsonism Relat Disord; 2016 Apr; 25():52-7. PubMed ID: 26905015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measuring quality of life in palliative care for Parkinson's disease: A clinimetric comparison.
    Holden SK; Koljack CE; Prizer LP; Sillau SH; Miyasaki JM; Kluger BM
    Parkinsonism Relat Disord; 2019 Aug; 65():172-177. PubMed ID: 31253494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-reported outcome measures in Huntington disease: Quality of life in neurological disorders (Neuro-QoL) social functioning measures.
    Carlozzi NE; Hahn EA; Goodnight SM; Kratz AL; Paulsen JS; Stout JC; Frank S; Miner JA; Cella D; Gershon RC; Schilling SG; Ready RE
    Psychol Assess; 2018 Apr; 30(4):450-458. PubMed ID: 28557480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cultural adaptation and application of the IBS-QOL in China: a disease-specific quality-of-life questionnaire.
    Huang WW; Zhou FS; Bushnell DM; Diakite C; Yang XH
    Qual Life Res; 2007 Aug; 16(6):991-6. PubMed ID: 17440830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the Korean version of the 39-Item Parkinson's Disease Questionnaire (PDQ-39).
    Park HJ; Sohng KY; Kim S
    Asian Nurs Res (Korean Soc Nurs Sci); 2014 Mar; 8(1):67-74. PubMed ID: 25030495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responsiveness to Change Over Time: An Examination of the Neuro-QoL Social Function Measures in Persons with Huntington's Disease.
    Carlozzi NE; Boileau NR; Hahn EA; Barton SK; Cella D; McCormack MK; Ready RE
    J Huntingtons Dis; 2020; 9(1):83-97. PubMed ID: 31744014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.